Haselmeier, a provider of self-injection devices, has been granted a drug manufacturing license at its production site in Buchen, Odenwald, in accordance with §13 of the Medicines Act (Arzneimittelgesetz – AMG) or according to Art. 40 of Directive 2001/83/EC. The company can now offer pharmaceutical and biopharmaceutical companies an assembly, labeling and packaging service. Konrad Betzler, chief quality officer of Haselmeier, said,  “I am pleased that, after extensive preparatory...